Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): C Fielder Camm , A John Camm Added: 3 years ago
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder, with an autosomal dominant mechanism of inheritance.1,2 It has a prevalence of 1 in 500 within the general population, and is a known cause of sudden cardiac death.2,3 Recognised autosomal dominant mutations within sarcomere proteins are found in 55 % of adolescents with sporadic HCM.4 Characteristic echocardiographic… View more

Heart Failure
Author(s): Amar Trivedi , Bradley P Knight Added: 3 years ago
Hypertrophic cardiomyopathy (HCM), a genetic sarcomeric disorder associated with myocyte disarray and scar deposition, is intimately linked to sudden cardiac death (SCD) due to malignant ventricular arrhythmias. In the first modern published description of the disease in 1958, Dr Donald Teare describes the case of a 14-year-old male who collapsed while being chased around his school’s playground… View more

Heart Failure

Electrophysiology & Arrhythmia
Author(s): Rajiv Sankaranarayanan , Eleanor J Fleming , Clifford J Garratt Added: 3 years ago
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disorder worldwide with a prevalence of 1 in 500 in the general population.1 It can be defined as a condition that is typified by unexplained left ventricular hypertrophy (LVH) in the absence of other cardiac or non-cardiac conditions that could produce hypertrophy of similar proportions.2 The condition was the first… View more

Heart Failure
Author(s): Ethan J Rowin , Martin S Maron Added: 3 years ago
Hypertrophic cardiomyopathy (HCM), the most common genetic cardiomyopathy, is present in one in 500 of the general population and is caused by over 1,400 mutations in at least 11 genes encoding the cardiac sarcomere.1–4 Although the majority of patients with HCM remain asymptomatic with near-normal longevity, a small, but important, subset of patients are at increased risk for a wide range of… View more

Imaging & Diagnostics

Heart Failure
Research Area(s) / Expertise:
EHRA 23: TEMPO-HCM: Extended ECG Monitoring in HCM
Author(s): Juan Caro Codón Added: 1 year ago
EHRA 2023 — Dr Juan Caro Codón (La Paz University Hospital, Madrid, ES) discusses the findings from the TEMPO-HCM study investigating extended ECG monitoring in hypertrophic cardiomyopathy (HCM) patients. This was a prospective, observational, multicenter trial that included patients with a diagnosis of hypertrophic cardiomyopathy. Investigators compared the rate of clinically relevant… View more

Electrophysiology & Arrhythmia
Research Area(s) / Expertise:
Florian Rader
Job title: Director
Dr Florian Rader is the medical director of the hypertension center at Cedars-Sinai Heart Institute in Los Angeles, California. His clinical research focuses on hypertrophic cardiomyopathy and hypertensive patients. View more
Juan Pablo Kaski
Job title: Associate Professor
Prof Kaski is an Associate Professor at theCentre for Inherited Cardiovascular Diseases, UCL, London, UK. He is also a consultant paedriatric cardiologist, and Director of the Inherited Cardiovascular Diseases Unit at the Great Ormond Street Hospital for Children NHS Trust, UK. For his work on the genetic basis of pre-adolescent hypertrophic cardiomyopathy, Prof Kaski was awarded the Young… View more
Dr Ahmad Masri M.D., M.S. trained in Internal Medicine at the Cleveland Clinic. He specialises in caring for patients with conditions that result in abnormally thickened hearts, such as hypertrophic cardiomyopathy, amyloidosis and Fabry’s disease. View more